Opening book details…
About this Medicine article
LB4. A Phase 3, Randomized, Controlled Clinical Trial of Bictegravir in a Fixed-Dose Combination, B/F/TAF, vs. ABC/DTG/3TC in Treatment-Naïve Adults at Week 96 by Wohl, David A; Yazdanpanah, Yazdan; Baumgarten, Axel; Clarke, Amanda; Thompson, Melanie; Brinson, Cynthia; Hagins, Debbie; Ramgopal, Moti; Antinori, Andrea; Wei, Xuelian; White, Kirsten; Collins, Sean; Cheng, Andrew; Quirk, Erin; Martin, Hal is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Wohl, David A; Yazdanpanah, Yazdan; Baumgarten, Axel; Clarke, Amanda; Thompson, Melanie; Brinson, Cynthia; Hagins, Debbie; Ramgopal, Moti; Antinori, Andrea; Wei, Xuelian; White, Kirsten; Collins, Sean; Cheng, Andrew; Quirk, Erin; Martin, Hal
- Publisher
- Oxford University Press; [Oxford]: Oxford University Press; Oxford University Press (OUP) (ISSN 2328-8957)
- Published
- 2018
- Language
- EN
- Field
- Medicine (Health Sciences)